Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enanta Pharmaceuticals Inc (ENTA) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enanta Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1177648.
Total stock buying since 2013: $5,327,657.
Total stock sales since 2013: $95,044,056.
Total stock option exercises since 2013: $15,269,765.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 45,000 | $256,050 | 0 | $0 | 0 | $0 |
| 2024 | 0 | $0 | 34,967 | $407,322 | 10,562 | $94,952 |
| 2023 | 0 | $0 | 140,552 | $5,092,887 | 110,486 | $1,653,982 |
| 2022 | 0 | $0 | 138,700 | $9,836,417 | 170,891 | $6,383,775 |
| 2021 | 0 | $0 | 51,086 | $3,763,590 | 54,263 | $2,017,853 |
| 2020 | 0 | $0 | 10,000 | $612,410 | 37,428 | $200,939 |
| 2019 | 0 | $0 | 79,311 | $7,429,833 | 112,330 | $1,834,192 |
| 2018 | 0 | $0 | 134,890 | $14,396,882 | 67,988 | $1,872,657 |
| 2017 | 0 | $0 | 13,921 | $488,501 | 29,274 | $87,060 |
| 2016 | 2,500 | $66,302 | 13,921 | $437,606 | 206,693 | $523,859 |
| 2015 | 2,400 | $80,481 | 147,000 | $6,003,187 | 126,704 | $172,922 |
| 2014 | 1,000 | $38,950 | 970,078 | $38,121,923 | 490,542 | $365,808 |
| 2013 | 348,991 | $4,885,874 | 352,669 | $8,453,498 | 84,265 | $61,766 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 45,000 | $256,050 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 15,756 | $126,989 | 0 | $0 |
| 2024-07 | 0 | $0 | 11,945 | $190,744 | 5,375 | $48,321 |
| 2024-06 | 0 | $0 | 7,266 | $89,589 | 0 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 5,187 | $46,631 |
| 2023-12 | 0 | $0 | 34,545 | $324,863 | 0 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 6,667 | $200,010 |
| 2023-03 | 0 | $0 | 101,007 | $4,497,899 | 101,007 | $1,414,098 |
| 2023-02 | 0 | $0 | 5,000 | $270,125 | 0 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 2,812 | $39,874 |
| 2022-12 | 0 | $0 | 0 | $0 | 18,648 | $458,728 |
| 2022-06 | 0 | $0 | 0 | $0 | 3,480 | $40,959 |
| 2022-04 | 0 | $0 | 83,344 | $5,954,764 | 83,344 | $3,551,524 |
| 2022-03 | 0 | $0 | 42,820 | $3,002,504 | 42,820 | $1,753,676 |
| 2022-01 | 0 | $0 | 12,536 | $879,149 | 22,599 | $578,888 |
| 2021-12 | 0 | $0 | 13,523 | $1,182,599 | 13,523 | $621,922 |
| 2021-11 | 0 | $0 | 9,547 | $813,213 | 9,547 | $463,220 |
| 2021-10 | 0 | $0 | 17,500 | $1,227,620 | 17,500 | $760,549 |
| 2021-09 | 0 | $0 | 4,516 | $266,696 | 0 | $0 |
| 2021-01 | 0 | $0 | 6,000 | $273,462 | 13,693 | $172,162 |
| 2020-12 | 0 | $0 | 0 | $0 | 27,542 | $50,010 |
| 2020-11 | 0 | $0 | 0 | $0 | 3,480 | $8,849 |
| 2020-08 | 0 | $0 | 0 | $0 | 1,666 | $49,980 |
| 2020-05 | 0 | $0 | 0 | $0 | 1,740 | $2,100 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-12 | Luly Jay R. (President and CEO) | Buy | 45,000 | 5.69 | 256,050 |
| 2024-12-06 | Rottinghaus Scott T. (Chief Medical Officer) | Sale | 866 | 8.06 | 6,979 |
| 2024-12-06 | Luu Brendan (Chief Business Officer) | Sale | 2,283 | 8.06 | 18,400 |
| 2024-12-06 | Kieffer Tara Lynn (Chief Product Strategy Officer) | Sale | 2,283 | 8.06 | 18,400 |
| 2024-12-06 | Or Yat Sun (Chief Scientific Officer) | Sale | 2,591 | 8.06 | 20,883 |
| 2024-12-06 | Luly Jay R. (President and CEO) | Sale | 5,142 | 8.06 | 41,444 |
| 2024-12-06 | Mellett Paul J (Chief Fin. & Admin Officer) | Sale | 2,591 | 8.06 | 20,883 |
| 2024-07-15 | Rottinghaus Scott T. (Chief Medical Officer) | Sale | 5,375 | 17.08 | 91,804 |
| 2024-07-15 | Rottinghaus Scott T. (Chief Medical Officer) | Option Ex | 5,375 | 8.99 | 48,321 |
| 2024-07-12 | Rottinghaus Scott T. (Chief Medical Officer) | Sale | 2,271 | 15.04 | 34,155 |
| 2024-07-11 | Rottinghaus Scott T. (Chief Medical Officer) | Sale | 4,299 | 15.07 | 64,785 |
| 2024-06-17 | Kieffer Tara Lynn (Chief Product Strategy Officer) | Sale | 7,266 | 12.33 | 89,589 |
| 2024-02-26 | Gardiner Nathaniel S. (Chief Legal Officer) | Option Ex | 5,187 | 8.99 | 46,631 |
| 2023-12-13 | Vance Terry (Director) | Sale | 15,295 | 9.12 | 139,490 |
| 2023-12-05 | Rottinghaus Scott T. (Sr. VP & CMO) | Sale | 534 | 9.63 | 5,142 |
| 2023-12-05 | Luu Brendan (Sr. VP, Business Dev.) | Sale | 2,125 | 9.63 | 20,463 |
| 2023-12-05 | Kieffer Tara Lynn (Sr. VP, New Prod. Strat. & Dev) | Sale | 2,125 | 9.63 | 20,463 |
| 2023-12-05 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Sale | 2,412 | 9.63 | 23,227 |
| 2023-12-05 | Or Yat Sun (Sr. VP, R&D & CSO) | Sale | 2,412 | 9.63 | 23,227 |
| 2023-12-05 | Luly Jay R. (President and CEO) | Sale | 7,230 | 9.63 | 69,624 |
| 2023-12-05 | Mellett Paul J (Sr. VP, Finance & Admin. & CFO) | Sale | 2,412 | 9.63 | 23,227 |
| 2023-04-18 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 6,667 | 30.00 | 200,010 |
| 2023-03-15 | Or Yat Sun (Sr. VP & CSO) | Sale | 27,850 | 44.19 | 1,230,690 |
| 2023-03-15 | Or Yat Sun (Sr. VP & CSO) | Option Ex | 27,850 | 14.00 | 389,900 |
| 2023-03-15 | Mellett Paul J (Treasurer and CFO) | Sale | 20,880 | 44.20 | 922,790 |
| 2023-03-15 | Mellett Paul J (Treasurer and CFO) | Option Ex | 20,880 | 14.00 | 292,320 |
| 2023-03-13 | Luly Jay R. (President and CEO) | Sale | 27,912 | 45.42 | 1,267,679 |
| 2023-03-13 | Luly Jay R. (President and CEO) | Option Ex | 27,912 | 14.00 | 390,768 |
| 2023-02-09 | Mellett Paul J (Treasurer and CFO) | Sale | 5,000 | 54.02 | 270,125 |
| 2023-01-09 | Mellett Paul J (Treasurer and CFO) | Option Ex | 2,812 | 14.18 | 39,874 |
| 2022-12-19 | Luly Jay R. (President and CEO) | Option Ex | 14,500 | 27.58 | 399,910 |
| 2022-12-19 | Mellett Paul J (Treasurer and CFO) | Option Ex | 4,148 | 14.18 | 58,818 |
| 2022-06-17 | Mellett Paul J (Treasurer and CFO) | Option Ex | 3,480 | 11.77 | 40,959 |
| 2022-04-04 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 32,785 | 72.08 | 2,363,306 |
| 2022-04-04 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 32,785 | 51.81 | 1,698,689 |
| 2022-04-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 50,559 | 71.03 | 3,591,458 |
| 2022-04-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 50,559 | 36.65 | 1,852,835 |
| 2022-03-21 | Carter Bruce L A (Director) | Sale | 6,000 | 68.03 | 408,168 |
| 2022-03-21 | Carter Bruce L A (Director) | Option Ex | 6,000 | 25.58 | 153,480 |
| 2022-03-02 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 12,481 | 70.07 | 874,543 |
| 2022-03-02 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 12,481 | 43.46 | 542,424 |
| 2022-03-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 24,339 | 70.66 | 1,719,793 |
| 2022-03-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 24,339 | 43.46 | 1,057,772 |
| 2022-01-15 | Luly Jay R. (President and CEO) | Option Ex | 10,063 | 11.77 | 118,441 |
| 2022-01-11 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 12,536 | 70.13 | 879,149 |
| 2022-01-11 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 12,536 | 36.73 | 460,447 |
| 2021-12-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 13,523 | 87.45 | 1,182,599 |
| 2021-12-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 13,523 | 45.99 | 621,922 |
| 2021-11-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 9,547 | 85.18 | 813,213 |
| 2021-11-01 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 9,547 | 48.52 | 463,220 |
| 2021-10-11 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,047 | 70.34 | 284,686 |
| 2021-10-11 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 4,047 | 43.46 | 175,882 |
| 2021-10-08 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 13,453 | 70.09 | 942,934 |
| 2021-10-08 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 13,453 | 43.46 | 584,667 |
| 2021-09-15 | Luly Jay R. (President and CEO) | Sale | 4,516 | 59.06 | 266,696 |
| 2021-01-26 | Or Yat Sun (Sr. VP & CSO) | Option Ex | 13,693 | 12.57 | 172,162 |
| 2021-01-08 | Mellett Paul J (Treasurer and CFO) | Sale | 6,000 | 45.58 | 273,462 |
| 2020-12-15 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 5,250 | .00 | 0 |
| 2020-12-15 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 5,250 | .00 | 0 |
| 2020-12-15 | Or Yat Sun (Sr. VP & CSO) | Option Ex | 5,250 | .00 | 0 |
| 2020-12-15 | Luly Jay R. (President and CEO) | Option Ex | 7,500 | .00 | 0 |
| 2020-12-15 | Mellett Paul J (Treasurer and CFO) | Option Ex | 2,625 | .00 | 0 |
| 2020-12-03 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 1,667 | 30.00 | 50,010 |
| 2020-11-11 | Mellett Paul J (Treasurer and CFO) | Option Ex | 3,480 | 2.54 | 8,849 |
| 2020-08-05 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 1,666 | 30.00 | 49,980 |
| 2020-05-05 | Mellett Paul J (Treasurer and CFO) | Option Ex | 1,740 | 1.21 | 2,100 |
| 2020-03-12 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 3,000 | 30.00 | 90,000 |
| 2020-01-02 | Mellett Paul J (Treasurer and CFO) | Sale | 10,000 | 61.24 | 612,410 |
| 2019-12-16 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 5,250 | .00 | 0 |
| 2019-12-16 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 5,250 | .00 | 0 |
| 2019-12-16 | Or Yat Sun (Sr. VP & CSO) | Option Ex | 5,250 | .00 | 0 |
| 2019-12-16 | Luly Jay R. (President and CEO) | Option Ex | 7,500 | .00 | 0 |
| 2019-12-16 | Mellett Paul J (Treasurer and CFO) | Option Ex | 2,625 | .00 | 0 |
| 2019-11-22 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 1,592 | 31.42 | 50,020 |
| 2019-10-08 | Luly Jay R. (President and CEO) | Option Ex | 7,052 | 14.18 | 99,997 |
| 2019-09-27 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 5,000 | 30.00 | 150,000 |
| 2019-06-26 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 3,295 | 31.42 | 103,528 |
| 2019-03-11 | Carter Bruce L A (Director) | Sale | 1,546 | 99.16 | 153,301 |
| 2019-03-11 | Carter Bruce L A (Director) | Option Ex | 1,546 | 23.40 | 36,176 |
| 2019-03-06 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 2,519 | 33.06 | 83,278 |
| 2019-03-04 | Golumbeski George (Director) | Sale | 9,280 | 103.65 | 961,899 |
| 2019-03-04 | Golumbeski George (Director) | Option Ex | 9,280 | 36.61 | 339,740 |
| 2019-03-01 | Or Yat Sun (Sr. VP & CSO) | Sale | 10,000 | 103.58 | 1,035,789 |
| 2019-02-13 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Sale | 3,270 | 95.28 | 311,562 |
| 2019-02-13 | Mellett Paul J (Treasurer and CFO) | Option Ex | 6,960 | 1.51 | 10,502 |
| 2019-02-12 | Golumbeski George (Director) | Sale | 11,228 | 90.07 | 1,011,305 |
| 2019-02-12 | Golumbeski George (Director) | Option Ex | 11,228 | 27.30 | 306,524 |
| 2019-02-12 | Or Yat Sun (Sr. VP & CSO) | Sale | 6,297 | 90.07 | 567,170 |
| 2019-02-12 | Carter Bruce L A (Director) | Sale | 5,000 | 90.00 | 450,000 |
| 2019-02-12 | Carter Bruce L A (Director) | Option Ex | 5,000 | 23.40 | 117,000 |
| 2019-02-11 | Golumbeski George (Director) | Sale | 2,272 | 90.03 | 204,552 |
| 2019-02-11 | Golumbeski George (Director) | Option Ex | 2,272 | 25.58 | 58,117 |
| 2019-02-11 | Or Yat Sun (Sr. VP & CSO) | Sale | 27,684 | 89.88 | 2,488,154 |
| 2019-02-11 | Or Yat Sun (Sr. VP & CSO) | Option Ex | 25,977 | 13.32 | 345,935 |
| 2019-02-11 | Carter Bruce L A (Director) | Sale | 2,734 | 90.02 | 246,101 |
| 2019-02-11 | Carter Bruce L A (Director) | Option Ex | 2,734 | 23.40 | 63,975 |
| 2019-01-22 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 2,000 | 34.70 | 69,400 |
| 2018-12-06 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 2,000 | 34.70 | 69,400 |
| 2018-12-03 | Ocain Tim (Senior Vice President) | Option Ex | 2,000 | 32.27 | 64,540 |
| 2018-10-01 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 1,500 | 34.70 | 52,050 |
| 2018-10-01 | Ocain Tim (Senior Vice President) | Sale | 25,000 | 83.71 | 2,092,700 |
| 2018-10-01 | Ocain Tim (Senior Vice President) | Option Ex | 25,000 | 26.12 | 653,125 |
| 2018-09-20 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,155 | 94.88 | 394,230 |
| 2018-09-20 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-08-20 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,155 | 92.06 | 382,517 |
| 2018-08-20 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-07-27 | Luly Jay R. (President and CEO) | Option Ex | 8,498 | 11.77 | 99,987 |
| 2018-07-18 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 5,045 | 124.98 | 630,519 |
| 2018-07-18 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-07-06 | Luly Jay R. (President and CEO) | Sale | 32,023 | 125.75 | 4,027,020 |
| 2018-07-05 | Luly Jay R. (President and CEO) | Sale | 2,977 | 123.81 | 368,567 |
| 2018-06-18 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,155 | 114.96 | 477,658 |
| 2018-06-18 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-06-18 | Mellett Paul J (Treasurer and CFO) | Option Ex | 6,960 | 1.98 | 13,801 |
| 2018-06-11 | Mellett Paul J (Treasurer and CFO) | Sale | 15,000 | 120.17 | 1,802,490 |
| 2018-05-17 | Luly Jay R. (President and CEO) | Sale | 10,968 | 105.83 | 1,160,743 |
| 2018-05-16 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,155 | 104.74 | 435,190 |
| 2018-05-16 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-05-16 | Luly Jay R. (President and CEO) | Sale | 14,032 | 105.82 | 1,484,908 |
| 2018-04-16 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Sale | 4,225 | 85.52 | 361,309 |
| 2018-04-16 | Adda Nathalie (Sr. VP & Chief Medical Officer) | Option Ex | 2,955 | 43.46 | 128,424 |
| 2018-03-19 | Mellett Paul J (Treasurer and CFO) | Sale | 9,000 | 86.56 | 779,031 |
| 2018-02-08 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Option Ex | 4,300 | 34.70 | 149,210 |
| 2017-04-11 | Mellett Paul J (Treasurer and CFO) | Option Ex | 29,274 | 2.97 | 87,060 |
| 2017-01-04 | Or Yat Sun (Chief Scientific Officer) | Sale | 13,921 | 35.09 | 488,501 |
| 2016-11-29 | Or Yat Sun (Chief Scientific Officer) | Sale | 13,921 | 31.43 | 437,606 |
| 2016-06-10 | Luly Jay R. (President and CEO) | Option Ex | 41,645 | 2.97 | 123,852 |
| 2016-05-11 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Buy | 500 | 24.45 | 12,222 |
| 2016-05-10 | Luly Jay R. (President and CEO) | Option Ex | 25,000 | 2.97 | 74,350 |
| 2016-03-09 | Luly Jay R. (President and CEO) | Option Ex | 18,561 | 2.54 | 47,200 |
| 2016-02-12 | Vance Terry (Director) | Buy | 2,000 | 27.04 | 54,080 |
| 2016-01-19 | Or Yat Sun (Chief Scientific Officer) | Option Ex | 42,922 | 2.54 | 109,150 |
| 2016-01-04 | Or Yat Sun (Chief Scientific Officer) | Option Ex | 78,565 | 2.15 | 169,307 |
| 2015-11-24 | Mellett Paul J (Treasurer and CFO) | Sale | 6,000 | 31.23 | 187,368 |
| 2015-10-23 | Luly Jay R. (President and CEO) | Option Ex | 68,700 | 1.50 | 102,912 |
| 2015-10-15 | Mellett Paul J (Treasurer and CFO) | Sale | 7,500 | 40.10 | 300,742 |
| 2015-09-08 | Mellett Paul J (Treasurer and CFO) | Sale | 7,500 | 39.78 | 298,350 |
| 2015-08-10 | Or Yat Sun (Chief Scientific Officer) | Sale | 3,750 | 42.96 | 161,100 |
| 2015-08-07 | Mellett Paul J (Treasurer and CFO) | Sale | 7,500 | 43.92 | 329,370 |
| 2015-07-13 | Or Yat Sun (Chief Scientific Officer) | Sale | 3,750 | 46.40 | 174,000 |
| 2015-07-13 | Mellett Paul J (Treasurer and CFO) | Sale | 7,500 | 46.39 | 347,895 |
| 2015-06-11 | Or Yat Sun (Chief Scientific Officer) | Sale | 3,750 | 42.47 | 159,266 |
| 2015-06-11 | Mellett Paul J (Treasurer and CFO) | Sale | 7,500 | 42.51 | 318,810 |
| 2015-06-05 | Or Yat Sun (Chief Scientific Officer) | Sale | 10,750 | 42.02 | 451,661 |
| 2015-05-19 | Mellett Paul J (Treasurer and CFO) | Sale | 24,000 | 40.13 | 963,096 |
| 2015-05-11 | Or Yat Sun (Chief Scientific Officer) | Sale | 8,000 | 36.13 | 289,048 |
| 2015-03-09 | Luly Jay R. (President and CEO) | Sale | 15,000 | 34.03 | 510,390 |
| 2015-02-20 | Luly Jay R. (President and CEO) | Sale | 15,000 | 35.35 | 530,295 |
| 2015-02-19 | Buckley Stephen Jr. (Director) | Buy | 600 | 34.20 | 20,520 |
| 2015-02-18 | Buckley Stephen Jr. (Director) | Buy | 400 | 33.69 | 13,476 |
| 2015-02-17 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Buy | 1,000 | 33.28 | 33,285 |
| 2015-02-13 | Gardiner Nathaniel S. (Sr. VP & General Counsel) | Buy | 400 | 33.00 | 13,200 |
| 2015-01-16 | Mellett Paul J (Treasurer and CFO) | Sale | 4,500 | 49.50 | 222,736 |
| 2015-01-06 | Or Yat Sun (Chief Scientific Officer) | Option Ex | 58,004 | 1.21 | 70,010 |
| 2015-01-05 | Luly Jay R. (President and CEO) | Sale | 15,000 | 50.60 | 759,060 |
| 2014-12-12 | Luly Jay R. (President and CEO) | Option Ex | 7,055 | .73 | 5,171 |
| 2014-12-01 | Luly Jay R. (President and CEO) | Sale | 15,000 | 45.98 | 689,625 |
| 2014-11-28 | Mellett Paul J (Treasurer and CFO) | Sale | 6,000 | 47.87 | 287,196 |
| 2014-11-03 | Luly Jay R. (President and CEO) | Sale | 15,000 | 42.71 | 640,680 |
| 2014-10-20 | Mellett Paul J (Treasurer and CFO) | Sale | 4,000 | 45.30 | 181,180 |
| 2014-09-15 | Mellett Paul J (Treasurer and CFO) | Sale | 10,000 | 40.16 | 401,629 |
| 2014-08-14 | Buckley Stephen Jr. (Director) | Buy | 1,000 | 38.95 | 38,950 |
| 2014-08-14 | Mellett Paul J (Treasurer and CFO) | Sale | 10,000 | 39.13 | 391,280 |
| 2014-08-13 | Or Yat Sun (Chief Scientific Officer) | Sale | 5,000 | 39.76 | 198,795 |
| 2014-08-05 | Or Yat Sun (Chief Scientific Officer) | Option Ex | 11,149 | 1.29 | 14,415 |
| 2014-07-14 | Mellett Paul J (Treasurer and CFO) | Sale | 20,000 | 40.16 | 803,180 |
| 2014-07-01 | Or Yat Sun (Chief Scientific Officer) | Sale | 5,000 | 42.59 | 212,935 |
| 2014-06-02 | Or Yat Sun (Chief Scientific Officer) | Sale | 5,000 | 37.76 | 188,800 |
| 2014-05-01 | Or Yat Sun (Chief Scientific Officer) | Sale | 5,000 | 36.76 | 183,795 |
| 2014-04-01 | Or Yat Sun (Chief Scientific Officer) | Sale | 10,000 | 39.95 | 399,450 |
| 2014-04-01 | Luly Jay R. (President and CEO) | Sale | 15,000 | 39.95 | 599,250 |
| 2014-03-24 | Or Yat Sun (Chief Scientific Officer) | Sale | 10,000 | 39.48 | 394,780 |
| 2014-03-12 | Mellett Paul J (Treasurer and CFO) | Option Ex | 92,132 | .73 | 67,532 |
| 2014-03-10 | Luly Jay R. (President and CEO) | Sale | 10,000 | 38.56 | 385,650 |
| 2014-03-04 | Schuhsler Helmut (10% Owner) | Sale | 430,263 | 38.82 | 16,701,088 |
| 2014-03-03 | Schuhsler Helmut (10% Owner) | Sale | 9,071 | 38.83 | 352,263 |
| 2014-02-26 | Schuhsler Helmut (10% Owner) | Sale | 53,589 | 39.93 | 2,139,862 |
| 2014-02-25 | Schuhsler Helmut (10% Owner) | Sale | 176,601 | 38.92 | 6,873,134 |
| 2014-02-24 | Goll Alexandra (10% Owner) | Sale | 52,597 | 39.51 | 2,078,054 |
| 2014-02-24 | Schuhsler Helmut (Director) | Sale | 52,597 | 39.51 | 2,078,054 |
| 2014-02-21 | Goll Alexandra (10% Owner) | Sale | 7,880 | 40.00 | 315,200 |
| 2014-02-21 | Schuhsler Helmut (Director) | Sale | 7,880 | 40.00 | 315,200 |
| 2014-02-18 | Goll Alexandra (10% Owner) | Sale | 10,000 | 40.19 | 401,850 |
| 2014-02-18 | Schuhsler Helmut (Director) | Sale | 13,000 | 40.32 | 524,147 |
| 2014-02-14 | Luly Jay R. (President and CEO) | Sale | 5,800 | 38.16 | 221,339 |
| 2014-01-10 | Luly Jay R. (President and CEO) | Option Ex | 251,119 | .73 | 184,070 |
| 2014-01-03 | Or Yat Sun (Chief Scientific Officer) | Option Ex | 129,087 | .73 | 94,620 |
| 2014-01-02 | Luly Jay R. (President and CEO) | Sale | 5,800 | 28.19 | 163,507 |
| 2013-12-11 | Afting Ernst-guenter (Director) | Sale | 15,000 | 37.16 | 557,460 |
| 2013-12-06 | Goldberg Marc E. (Director) | Sale | 6,861 | 27.93 | 191,614 |
| 2013-11-27 | Goldberg Marc E. (Director) | Sale | 15,554 | 26.08 | 405,601 |
| 2013-11-26 | Goldberg Marc E. (Director) | Sale | 34,446 | 25.61 | 882,127 |
| 2013-10-14 | Obp Iii - Holdings Llc (10% Owner) | Sale | 32,103 | 19.83 | 636,570 |
| 2013-10-11 | Obp Iii - Holdings Llc (10% Owner) | Sale | 198 | 21.05 | 4,167 |
| 2013-10-10 | Obp Iii - Holdings Llc (10% Owner) | Sale | 11,207 | 21.06 | 235,974 |
| 2013-10-09 | Obp Iii - Holdings Llc (10% Owner) | Sale | 25,000 | 22.00 | 550,000 |
| 2013-10-03 | Saints Capital Granite, Llc (10% Owner) | Sale | 4,100 | 22.85 | 93,668 |
| 2013-10-02 | Saints Capital Granite, Llc (10% Owner) | Sale | 8,200 | 23.66 | 193,995 |
| 2013-10-01 | Obp Iii - Holdings Llc | Sale | 185,700 | 23.54 | 4,371,563 |
| 2013-09-30 | Obp Iii - Holdings Llc | Sale | 14,300 | 23.13 | 330,759 |
| 2013-07-11 | Mellett Paul J (Treasurer and CFO) | Option Ex | 84,265 | .73 | 61,766 |
| 2013-03-26 | Obp Iii - Holdings Llc (10% Owner) | Buy | 66,474 | 14.00 | 930,636 |
| 2013-03-26 | Verdine Gregory L. (Director) | Buy | 3,324 | 14.00 | 46,536 |
| 2013-03-26 | Vance Terry (Director) | Buy | 13,295 | 14.00 | 186,130 |
| 2013-03-26 | Goll Alexandra (10% Owner) | Buy | 132,949 | 14.00 | 1,861,286 |
| 2013-03-26 | Schuhsler Helmut (Director) | Buy | 132,949 | 14.00 | 1,861,286 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enanta Pharmaceuticals Inc (symbol ENTA, CIK number 1177648) see the Securities and Exchange Commission (SEC) website.